Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
25.61
-0.39 (-1.50%)
At close: Mar 2, 2026, 4:00 PM EST
25.23
-0.38 (-1.48%)
Pre-market: Mar 3, 2026, 5:49 AM EST
Evommune Market Cap
Evommune has a market cap or net worth of $807.33 million as of March 3, 2026.
Market Cap
807.33M
Enterprise Value
732.04M
1-Year Change
n/a
Ranking
Category
Stock Price
$25.61
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $807.33M, an increase of 67.76%. That is a compound annual growth rate of 431.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 819.63M | 51.87% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 854.35M |
| Arvinas | 848.76M |
| SELLAS Life Sciences Group | 839.49M |
| Annexon | 834.71M |
| Janux Therapeutics | 827.92M |
| KalVista Pharmaceuticals | 822.89M |
| Prime Medicine | 817.92M |
| BridgeBio Oncology Therapeutics | 802.29M |